Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis
NCT03296345Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Jun 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in sickle cell disease (SCD), sponsored by UCSF Benioff Children's Hospital Oakland. Started Jun 2016; status: completed.
02
Drugs
ketamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT03296345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03296345.